Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases

Background: Several findings suggest that the amyloid precursor protein (APP) and the amyloid cascade may play a role in motor neuron disease (MND).Objective: Considering that dementia is one of the most frequently non-motor symptoms in ALS and that hippocampus is one of the brain areas with greater...

Full description

Bibliographic Details
Main Authors: Ulises Gomez-Pinedo, Rocio Nur Villar-Quiles, Lucia Galan, Jordi A. Matias-Guiu, Maria Soledad Benito-Martin, Antonio Guerrero-Sola, Teresa Moreno-Ramos, Jorge Matias-Guiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2016.00195/full
_version_ 1819267428161421312
author Ulises Gomez-Pinedo
Rocio Nur Villar-Quiles
Lucia Galan
Jordi A. Matias-Guiu
Maria Soledad Benito-Martin
Antonio Guerrero-Sola
Teresa Moreno-Ramos
Jorge Matias-Guiu
author_facet Ulises Gomez-Pinedo
Rocio Nur Villar-Quiles
Lucia Galan
Jordi A. Matias-Guiu
Maria Soledad Benito-Martin
Antonio Guerrero-Sola
Teresa Moreno-Ramos
Jorge Matias-Guiu
author_sort Ulises Gomez-Pinedo
collection DOAJ
description Background: Several findings suggest that the amyloid precursor protein (APP) and the amyloid cascade may play a role in motor neuron disease (MND).Objective: Considering that dementia is one of the most frequently non-motor symptoms in ALS and that hippocampus is one of the brain areas with greater presence of amyloid related changes in neurodegenerative diseases, our aim was to analyse the molecular markers of the amyloid cascade of APP in pathology studies of the hippocampus of autopsied patients with ALS and ALS-FTD.Methods: We included 9 patients with MND and 4 controls. Immunohistochemical studies and confocal microscopy were used to analyse the expression of APP, TDP-43, pho-TDP-43, Aβ, AICD peptide, Fe65 protein, and pho-TAU in the hippocampus of 7 patients with ALS, 2 patients with ALS-FTD, and 4 controls. These findings were correlated with clinical data.Results: Patients displayed increased expression of APP and Aβ peptide. The latter was correlated with cytoplasmic pho-TDP-43 expression. We also found decreased Fe65 expression. A parallel increase in AICD expression was not found. Patients showed increased expression of pho-TAU in the hippocampus. Findings were similar in patients with ALS and those with ALS-FTD, though more marked in the latter group.Conclusion: Post-mortem analyses showed that the amyloid cascade is activated in the hippocampus of patients with MND and correlated with cytoplasmic pho-TDP-43 expression. The number of intra- or extracellular aggregates of Aβ peptides was not significant.
first_indexed 2024-12-23T21:17:00Z
format Article
id doaj.art-a23a8eaf705c4210bedaaf92339bafc9
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-23T21:17:00Z
publishDate 2016-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-a23a8eaf705c4210bedaaf92339bafc92022-12-21T17:30:52ZengFrontiers Media S.A.Frontiers in Neurology1664-22952016-11-01710.3389/fneur.2016.00195221808Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseasesUlises Gomez-Pinedo0Rocio Nur Villar-Quiles1Lucia Galan2Jordi A. Matias-Guiu3Maria Soledad Benito-Martin4Antonio Guerrero-Sola5Teresa Moreno-Ramos6Jorge Matias-Guiu7Hospital Clinico San Carlos, IdISSCHospital Clínico San Carlos, IdISSC, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, SpainHospital Clínico San Carlos, IdISSC, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, SpainHospital Clínico San Carlos, IdISSC, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, SpainHospital Clinico San Carlos, IdISSCHospital Clínico San Carlos, IdISSC, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, SpainHospital Clínico San Carlos, IdISSC, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, SpainHospital Clínico San Carlos, IdISSC, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, SpainBackground: Several findings suggest that the amyloid precursor protein (APP) and the amyloid cascade may play a role in motor neuron disease (MND).Objective: Considering that dementia is one of the most frequently non-motor symptoms in ALS and that hippocampus is one of the brain areas with greater presence of amyloid related changes in neurodegenerative diseases, our aim was to analyse the molecular markers of the amyloid cascade of APP in pathology studies of the hippocampus of autopsied patients with ALS and ALS-FTD.Methods: We included 9 patients with MND and 4 controls. Immunohistochemical studies and confocal microscopy were used to analyse the expression of APP, TDP-43, pho-TDP-43, Aβ, AICD peptide, Fe65 protein, and pho-TAU in the hippocampus of 7 patients with ALS, 2 patients with ALS-FTD, and 4 controls. These findings were correlated with clinical data.Results: Patients displayed increased expression of APP and Aβ peptide. The latter was correlated with cytoplasmic pho-TDP-43 expression. We also found decreased Fe65 expression. A parallel increase in AICD expression was not found. Patients showed increased expression of pho-TAU in the hippocampus. Findings were similar in patients with ALS and those with ALS-FTD, though more marked in the latter group.Conclusion: Post-mortem analyses showed that the amyloid cascade is activated in the hippocampus of patients with MND and correlated with cytoplasmic pho-TDP-43 expression. The number of intra- or extracellular aggregates of Aβ peptides was not significant.http://journal.frontiersin.org/Journal/10.3389/fneur.2016.00195/fullAmyotrophic Lateral SclerosisFrontotemporal Dementiaamyloid precursor proteintau proteinTDP-43Aβ peptide
spellingShingle Ulises Gomez-Pinedo
Rocio Nur Villar-Quiles
Lucia Galan
Jordi A. Matias-Guiu
Maria Soledad Benito-Martin
Antonio Guerrero-Sola
Teresa Moreno-Ramos
Jorge Matias-Guiu
Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
Frontiers in Neurology
Amyotrophic Lateral Sclerosis
Frontotemporal Dementia
amyloid precursor protein
tau protein
TDP-43
Aβ peptide
title Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
title_full Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
title_fullStr Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
title_full_unstemmed Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
title_short Immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
title_sort immununochemical markers of the amyloid cascade in the hippocampus in motor neuron diseases
topic Amyotrophic Lateral Sclerosis
Frontotemporal Dementia
amyloid precursor protein
tau protein
TDP-43
Aβ peptide
url http://journal.frontiersin.org/Journal/10.3389/fneur.2016.00195/full
work_keys_str_mv AT ulisesgomezpinedo immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT rocionurvillarquiles immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT luciagalan immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT jordiamatiasguiu immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT mariasoledadbenitomartin immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT antonioguerrerosola immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT teresamorenoramos immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases
AT jorgematiasguiu immununochemicalmarkersoftheamyloidcascadeinthehippocampusinmotorneurondiseases